Kalbitor Has Potential as Treatment for Angioedema Attacks in Lupus Teens Who Have Normal C1-IHN Levels, Case Reports Contend
Kalbitor (ecallantide) is a potential treatment for angioedema attacks that do not respond to medication, in adolescents who also have systemic lupus erythematosus (SLE), even if they have normal levels of C1 inhibitor protein, two case reports suggest. The study combining the reports, “Ecallantide:…